v3.25.2
Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Sep. 30, 2024
Cash flows from operating activities:              
Net loss $ (3,036,765) $ (2,703,024) $ (2,662,065) $ (2,469,626) $ (5,739,789) $ (5,131,691)  
Adjustments to reconcile net loss to net cash used in operating activities:              
Depreciation and amortization         182,107 163,871  
Amortization of right of use asset         42,172 34,948  
Write-off of capitalized patent         0 62,073  
Write-off of fixed assets         1,201 14,459  
Gain on lease termination         0 (15,319) $ (15,319)
Stock-based compensation         714,625 745,600  
Decrease (increase) in operating assets:              
Accounts receivable         (7,483) 68,669  
Inventory         19,019 1,788  
Prepaid expenses and other assets         124,692 160,007  
Increase (decrease) in operating liabilities:              
Accounts payable         48,598 (174,464)  
Accrued expenses and other liabilities         229,212 135,175  
Lease liability         (39,655) (36,046)  
Net cash used in operating activities         (4,425,301) (3,970,930)  
Cash flows from investing activities:              
Purchase of property and equipment         (41,128) (64,036)  
Acquisition of intangible assets         (179,209) (174,968)  
Net cash used in investing activities         (220,337) (239,004)  
Cash flows from financing activities:              
Net proceeds from issuance of common stock and pre-funded warrants         0 15,724,818  
Exercise of options and warrants         110 86,757  
Payment of taxes related to restricted stock unit vestings         (91,769) (11,579)  
Net cash provided by (used in) financing activities         (91,659) 15,799,996  
Net increase (decrease) in cash and cash equivalents         (4,737,297) 11,590,062  
Cash and cash equivalents at beginning of period   $ 15,842,850   $ 8,474,835 15,842,850 8,474,835 $ 8,474,835
Cash and cash equivalents at end of period $ 11,105,553   $ 20,064,897   $ 11,105,553 $ 20,064,897  

Source